Financials
- Market Capitalization 11.37 B
- Employee 3 000
- Founded 1976
- CEO Kim Kelderman
- Website www.bio-techne.com
- Headquarter Minnesota, United States
- FIGI BBG000C15114
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
60.91
市销率
9.13
每股股息
0.32
股息收益率 %
0.45
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 780 | SMMT Summit Therapeutics Inc. - Common Stock | 15.52 USD | -9.40% | -9.24% | -14.54% | -21.85% | 12.38 B USD | ||
| 781 | BBIO BridgeBio Pharma, Inc. - Common Stock | 63.30 USD | -3.73% | -5.21% | -12.40% | +11.05% | 12.37 B USD | ||
| 867 | BMRN BioMarin Pharmaceutical Inc. - Common Stock | 54.38 USD | -1.82% | -3.07% | -17.33% | +3.90% | 10.53 B USD | ||
| 871 | MDGL Madrigal Pharmaceuticals, Inc. - Common Stock | 452.12 USD | -3.22% | -8.22% | -16.16% | +6.73% | 10.45 B USD |